Organigram Stock Price, News & Analysis (TSE:OGI) C$1.80 -0.02 (-1.10%) (As of 12/8/2023 ET) Add Compare Share Share Today's RangeC$1.78▼C$1.8650-Day RangeC$1.36▼C$1.9552-Week RangeC$1.35▼C$5.48Volume106,002 shsAverage Volume118,195 shsMarket CapitalizationC$146.09 millionP/E RatioN/ADividend YieldN/APrice TargetC$3.36 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlines About Organigram Stock (TSE:OGI)Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, gummies, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was incorporated in 2010 and is headquartered in Toronto, Canada.Read More OGI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OGI Stock News HeadlinesNovember 28, 2023 | markets.businessinsider.comOrganigram: Phylos Achieves First Milestone Under Loan Agreement; Increases InvestmentNovember 28, 2023 | finance.yahoo.comOrganigram Increases Investment in Phylos After Successful Milestone AchievementDecember 8, 2023 | Autonomix (Ad)How to Invest Early In the Next Potential Breakthrough Nerve-Sensing TechnologyAutonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 10, 2023 | markets.businessinsider.comOrganigram Names Paolo De Luca Interim CFONovember 10, 2023 | finance.yahoo.comOrganigram Announces Interim Chief Financial OfficerNovember 8, 2023 | theglobeandmail.comOrganigram stock jumps on $124-million investment from tobacco giant BATOctober 21, 2023 | theglobeandmail.comOrganiGram Holdings: Top 10 Undervalued Growth Stocks on TSX (OGI)October 10, 2023 | theglobeandmail.comClosing Bell: Organigram Holdings Inc flat on Tuesday (OGI)December 8, 2023 | Autonomix (Ad)How to Invest Early In the Next Potential Breakthrough Nerve-Sensing TechnologyAutonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comSeptember 30, 2023 | msn.comOrganigram Holdings: Earnings Growth Set To ContinueSeptember 25, 2023 | theglobeandmail.comLegal cannabis labels inflate THC potency contained in products, executives saySeptember 15, 2023 | finance.yahoo.comDigicann Ventures Announces Receipt of Last Portion of Final Earnout Milestone PaymentSeptember 1, 2023 | finance.yahoo.comOrganigram Announces Resignation of Board MemberAugust 28, 2023 | finance.yahoo.comOrganigram Launches First Range of THCV Products Derived from Moncton-Grown Whole FlowerJuly 14, 2023 | seekingalpha.comOrganigram Holdings reports Q3 results; initiates Q4 soft guidanceJuly 13, 2023 | finance.yahoo.comOrganigram Reports Third Quarter Fiscal 2023 ResultsJuly 12, 2023 | msn.comEarnings Outlook For OrganiGram HoldingsJuly 5, 2023 | finance.yahoo.comWill Organigram Holdings (TSE:OGI) Spend Its Cash Wisely?June 24, 2023 | fool.comOrganigram (TSX: OGI)June 8, 2023 | finance.yahoo.comThe Price Is Right For Organigram Holdings Inc. (TSE:OGI)May 25, 2023 | uk.finance.yahoo.comOGI - Organigram Holdings Inc.May 23, 2023 | msn.comOrganigram To Enter German Cannabis Market Via Sanity GroupMay 23, 2023 | finance.yahoo.comAgra Ventures Announces Receipt of Earnout Milestone PaymentMay 23, 2023 | finance.yahoo.comOrganigram to Enter German Market Supplying Sanity GroupMay 15, 2023 | msn.comOrganigram Is The Best Cannabis StockMay 10, 2023 | msn.comOrganigram Is Almost ThereApril 22, 2023 | theglobeandmail.comClosing Bell: Organigram Holdings Inc flat on Friday (OGI)See More Headlines Receive OGI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today12/08/2023Next Earnings (Estimated)1/11/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryCannabis SectorMedical Current SymbolTSE:OGI CUSIPN/A CIKN/A Webwww.organigram.ca Phone844-644-4726FaxN/AEmployees923Year FoundedN/APrice Target and Rating Average Stock Price TargetC$3.36 High Stock Price TargetC$6.50 Low Stock Price TargetC$1.50 Potential Upside/Downside+83.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)C($2.36) Trailing P/E RatioN/A Forward P/E Ratio31.25 P/E Growth0.42Net IncomeC$-221,750,000.00 Net Margins-137.67% Pretax MarginN/A Return on Equity-54.53% Return on Assets-5.56% Debt Debt-to-Equity Ratio0.06 Current Ratio4.54 Quick Ratio2.62 Sales & Book Value Annual SalesC$161.08 million Price / Sales0.92 Cash FlowC$0.47 per share Price / Cash Flow3.85 Book ValueC$3.75 per share Price / Book0.49Miscellaneous Outstanding Shares81,160,000Free FloatN/AMarket CapC$148.52 million OptionableNot Optionable Beta1.48 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMs. Beena G. Goldenberg (Age 60)CEO & Director Comp: $585.53kMr. Paolo De Luca C.A. (Age 50)C.F.A, Chief Strategy Officer & Interim CFO Comp: $395.52kMs. Helen Martin (Age 45)Chief Legal Officer & Corporate Secretary Comp: $390.53kMr. Timothy EmbergChief Commercial OfficerMs. Nathalie BattenVice President of OperationsMr. Geoff RiggsChief Information OfficerMax SchwartzDirector of Investor RelationsMs. Megan Amber McCraeSenior Vice President of Marketing & CommunicationsMs. Katrina May McFaddenChief People OfficerMr. Gregory Engel (Age 58)Special Advisor Comp: $589.16kMore ExecutivesKey CompetitorsLeaf MobileTSE:LEAFICC LabsCVE:ICCMedexus PharmaceuticalsCVE:MDPCipher PharmaceuticalsTSE:CPHHLS TherapeuticsTSE:HLSView All Competitors OGI Stock Analysis - Frequently Asked Questions Should I buy or sell Organigram stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Organigram in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" OGI shares. View OGI analyst ratings or view top-rated stocks. What is Organigram's stock price target for 2024? 1 equities research analysts have issued twelve-month price targets for Organigram's stock. Their OGI share price targets range from C$1.50 to C$6.50. On average, they predict the company's stock price to reach C$3.36 in the next twelve months. This suggests a possible upside of 86.5% from the stock's current price. View analysts price targets for OGI or view top-rated stocks among Wall Street analysts. How have OGI shares performed in 2023? Organigram's stock was trading at C$1.10 at the beginning of the year. Since then, OGI stock has increased by 63.6% and is now trading at C$1.80. View the best growth stocks for 2023 here. When is Organigram's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, January 11th 2024. View our OGI earnings forecast. What other stocks do shareholders of Organigram own? Based on aggregate information from My MarketBeat watchlists, some companies that other Organigram investors own include Aurora Cannabis (ACB), Innovative Industrial Properties (IIPR), Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), Aurora Cannabis (ACBFF), Green Organic Dutchman (TGOD), Charlotte's Web (CWBHF) and CannTrust (CTST). How do I buy shares of Organigram? Shares of OGI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:OGI) was last updated on 12/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.